SynthesisJournal of global health2016
Innovative financing for HIV response in sub-Saharan Africa.
Synthesis in Journal of global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Innovative domestic financing mechanisms for health in Africa: An evidence review.Journal of health services research & policy · 2024Pooled it
- Investigating strategies to enhance access to HIV services among children in Malawi: A multifaceted research approach, study protocol.PloS one · 2026Article
- Diaspora as partners: strengthening resilience of health systems and communities amidst aid volatility.BMJ global health · 2025Article
- Preventing HIV in women in Africa.Nature medicine · 2025Review
- Breaking barriers, changing paradigms: Africa's radical agenda for HIV sustainability.Frontiers in reproductive health · 2025Review
- Pharmacoeconomic perspectives on HIV: integrating data for long-term treatment and prevention.Frontiers in medicine · 2025Review
- The nature and contribution of innovative health financing mechanisms in the World Health Organization African region: A scoping review.Journal of global health · 2023Article
- A Financing Strategy to Expand Surgical Health Care.Global health, science and practice · 2023Review
- The political economy of health financing reforms in Zimbabwe: a scoping review.International journal for equity in health · 2022Article
- Diaspora engagement: a scoping review of diaspora involvement with strengthening health systems of their origin country.Global health action · 2022Article
- Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future "test and start" strategies.BMC health services research · 2020Article
- Contributing to health training in low and middle income countries - global health programmes' responsibility to be sustainable and impactful.Journal of global health · 2020Review
- The Impact of Business Cycle on Health Financing: Subsidized, Voluntary and Out-of-Pocket Health Spending.International journal of environmental research and public health · 2020Article
- Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria.PloS one · 2019Article
- HIV Prevention in Adolescents and Young People in the Eastern and Southern African Region: A Review of Key Challenges Impeding Actions for an Effective Response.The open AIDS journal · 2018Review
- Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach.BMC health services research · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub-Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates substantial long-term fiscal obligations for countries affected by HIV/AIDS. As donor assistance for health remains constrained, novel financing mechanisms are needed to augment funding domestic sources. We explore how Innovative Financing has been used to co-finance domestic HIV/AIDS responses. Based on analysis of non-health sectors, we identify innovative financing instruments that could be used in the HIV response.
methodsWe undertook a systematic review to identify innovative financing instruments used for (1) domestic HIV/AIDS financing in sub-Saharan Africa (2) international health financing and (3) financing in non-health sectors. We analyzed peer-reviewed and grey literature published between 2002 and 2014. We examined the nature and volume of funds mobilized with innovative financing, then in consultation with leading experts, identified instruments that held potential for financing the HIV response.
resultsOur analysis revealed three innovative financing instruments in use: Zimbabwe's AIDS Trust Fund (a tax/levy-based instrument), Botswana's National HIV/AIDS Prevention Support (BNAPS) International Bank for Reconstruction and Development (IBRD) Buy-Down (a debt conversion instrument), and Côte d'Ivoire's Debt2Health Debt Swap Agreement (a debt conversion instrument). Zimbabwe's AIDS Trust Fund generated US$ 52.7 million between 2008 and 2011, Botswana's IBRD Buy-Down generated US$ 20 million, and Côte d'Ivoire's Debt2Health Debt Swap Agreement generated US$ 27 million, at least half of which was to be invested in HIV/AIDS programs. Four additional categories of innovative financing instruments met our criteria for future use: (1) remittances and diaspora bonds (2) social and development impact bonds (3) sovereign wealth funds (4) risk and credit guarantees.
conclusionA limited number of innovative financing instruments contributed a very modest share of funding toward domestic HIV/AIDS programs. Several innovative financing instruments successfully applied in other sectors could be used to augment domestic financing toward HIV/AIDS programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.